pecific to the S1 subunit of S protein, particularly the RBD [5,89–10]. Therefore, the 2019-nCoV S-RBD is anticipated to be a key target for developing 2019-nCoV neutralizing mAbs. The neutralizing mAbs targeting non-RBD reg